SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

MEDICAMEN BIOTECH

BSE: 531146 19 Aug 2025
Healthcare
₹ 354.9
Medicamen Biotech Ltd. specializes in Pharmaceuticals within the Healthcare sector.

MEDICAMEN BIOTECH - Share Price & Details

Market Cap
₹480.0
High /Low
630.0 / 342.0
Stock P/E
50.6
Book Value
₹167.0
Dividend Yield
0.29
ROCE
5.39
ROE
₹3.39
Face Value
10.0
PEG Ratio
-2.31
EVEBITDA
₹24.1
Debt
33.2
CMP / FCF
-41.2
Debt to equity
₹0.16
NP Ann
6.56
High price all time
1,225
Piotroski score
₹3.0
Graham Number
166.0
No. Eq. Shares
1.36
Net CF
₹-11.0
Net profit
7.28
Price to book value
2.12
Interest Coverage
₹3.9
Low price all time
4.75
Industry PE
33.5
Reserves
₹200
Free Cash Flow
₹-9.26

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
MEDICAMEN BIOTECH LTD.389.1916.37384.491.21480.050.6
ALBERT DAVID LTD.926.0379.38705.6613.9146373.6
OXYGENTA PHARMACEUTICAL LIMITE495.16-21.53494.67-0.60456

Peer Comparison Chart


About MEDICAMEN BIOTECH

Medicamen Biotech Ltd., with Security Code 531146, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Medicamen Biotech (NSE:MEDICAMEQ) Is Paying Out A Dividend Of ₹1.00

(15 Aug 2025)
Medicamen Biotech Limited ( NSE:MEDICAMEQ ) has announced that it will pay a dividend of ₹1.00 per share on the 26th of...
Read more →

Medicamen Biotech Faces Significant Volatility Amid Declining Financial Performance

(13 Aug 2025)
Medicamen Biotech has faced notable volatility, hitting a new 52-week low and underperforming its sector. The stock has declined consecutively over the past...
Read more →

Medicamen Biotech Reports 30.75% PAT Growth Amid Rising Debt and Liquidity Concerns

(13 Aug 2025)
Medicamen Biotech announced its financial results for the quarter ending June 2025, revealing a Profit After Tax of Rs 4.55 crore,...
Read more →

Medicamen Biotech standalone net profit declines 27.43% in the June 2025 quarter

(13 Aug 2025)
Net profit of Medicamen Biotech declined 27.43% to Rs 1.64 crore in the quarter ended June 2025 as against Rs 2.26 crore during the previous...
Read more →

Medicamen Biotech consolidated net profit rises 59.26% in the June 2025 quarter

(13 Aug 2025)
Net profit of Medicamen Biotech rose 59.26% to Rs 2.15 crore in the quarter ended June 2025 as against Rs 1.35 crore during the previous...
Read more →

Medicamen Biotech Faces Ongoing Struggles Amidst Persistent Market Volatility

(13 Aug 2025)
Medicamen Biotech has faced notable volatility, reaching a new 52-week low and underperforming its sector. The stock has consistently traded below key...
Read more →

Company Updates